Rita de Cassia Cavaglieri
Overview
Explore the profile of Rita de Cassia Cavaglieri including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
176
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lima K, Rojas C, Nogueira F, Silva W, Cavaglieri R, Nardinelli L, et al.
EJHaem
. 2024 Dec;
5(6):1366-1369.
PMID: 39691248
No abstract available.
2.
Lima K, Nogueira F, Cipelli M, Carvalho M, Pereira-Martins D, Silva W, et al.
Eur J Pharmacol
. 2024 Jun;
977:176723.
PMID: 38851560
Acute lymphoblastic leukemia (ALL), a complex malignancy, displays varying expression profiles of PIP4K2-related genes in adult patients. While PIP4K2A expression is elevated in ALL bone marrow cells compared to healthy...
3.
Lima K, Carvalho M, Pereira-Martins D, Nogueira F, de Miranda L, do Nascimento M, et al.
Int J Mol Sci
. 2023 Dec;
24(23).
PMID: 38069220
Phosphatidylinositol-5-phosphate 4-kinase type 2 (PIP4K2) protein family members (PIP4K2A, PIP4K2B, and PIP4K2C) participate in the generation of PIP,P, which acts as a secondary messenger in signal transduction, a substrate for...
4.
Lima K, Pereira-Martins D, de Miranda L, Coelho-Silva J, da Silva Leandro G, Weinhauser I, et al.
Blood Cancer J
. 2022 Nov;
12(11):151.
PMID: 36347832
The treatment of acute leukemia is challenging because of the genetic heterogeneity between and within patients. Leukemic stem cells (LSCs) are relatively drug-resistant and frequently relapse. Their plasticity and capacity...
5.
Fernandes L, Bassi Stern A, Cavaglieri R, Nogueira F, Domont G, Palmisano G, et al.
J Proteomics
. 2016 Jun;
151:12-23.
PMID: 27343758
Significance: CML patients treated with tyrosine kinase inhibitors (TKIs) have showed a 5-year estimated overall survival of 89%, with cumulative complete cytogenetic response of 87%. However, development of drug resistance...
6.
Eid A, Ford B, Bhandary B, Cavaglieri R, Block K, Barnes J, et al.
Diabetes
. 2013 Apr;
62(8):2935-47.
PMID: 23557706
Podocyte apoptosis is a critical mechanism for excessive loss of urinary albumin that eventuates in kidney fibrosis. Pharmacological doses of the mammalian target of rapamycin (mTOR) inhibitor rapamycin reduce albuminuria...
7.
de Lara Janz F, Debes A, Cavaglieri R, Duarte S, Romao C, Moron A, et al.
J Biomed Biotechnol
. 2012 Jun;
2012:649353.
PMID: 22665987
Amniotic fluid (AF) was described as a potential source of mesenchymal stem cells (MSCs) for biomedicine purposes. Therefore, evaluation of alternative cryoprotectants and freezing protocols capable to maintain the viability...
8.
Day R, Cavaglieri R, Tabatabaimir H, Mantravadi V, Lee M, Barnes J, et al.
Cell Signal
. 2010 Jul;
22(12):1849-57.
PMID: 20667471
Angiotensin II (Ang II) and vascular endothelial growth factor (VEGF) are important mediators of kidney injury in diabetes. Acute hyperglycemia increased synthesis of intrarenal Ang I and Ang II and...
9.
Graciano M, Cavaglieri R, Delle H, Dominguez W, Casarini D, Malheiros D, et al.
J Am Soc Nephrol
. 2004 Jun;
15(7):1805-15.
PMID: 15213268
Locally generated angiotensin II (AngII) may be involved in the pathogenic mechanisms of chronic renal diseases. Renal expression of AngII and other components of the renin-angiotensin system (RAS) were analyzed...